InVivoPlus anti-mouse VEGFR-2
BP0060
ApplicationsWestern Blot, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoPlus anti-mouse VEGFR-2
- Delivery Days Customer7
- ApplicationsWestern Blot, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDDC101
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG1
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Arulanandam R, Batenchuk C, Angarita FA, et al. VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection. Cancer Cell. 2015,28(2):210-24. doi: 10.1016/j.ccell.2015.06.009Read this paper
- Lee HJ, Yoon C, Park DJ, et al. Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature. Int J Radiat Oncol Biol Phys. 2015,91(3):621-30. doi: 10.1016/j.ijrobp.2014.10.047Read this paper
- Ding X, Lucas T, Marcuzzi GP, et al. Distinct functions of epidermal and myeloid-derived VEGF-A in skin tumorigenesis mediated by HPV8. Cancer Res. 2015,75(2):330-43. doi: 10.1158/0008-5472.CAN-13-3007Read this paper
- Kizhatil K, Ryan M, Marchant JK, et al. Schlemm's canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process. PLoS Biol. 2014,12(7):e1001912. doi: 10.1371/journal.pbio.1001912Read this paper
- Larrayoz M, Pio R, Pajares MJ, et al. Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype. EMBO Mol Med. 2014,6(4):539-50. doi: 10.1002/emmm.201303214Read this paper
- Villalta SA, Lang J, Kubeck S, et al. Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function. Diabetes. 2013,62(8):2870-8. doi: 10.2337/db12-1619Read this paper
- Chatterjee S, Wang Y, Duncan MK, et al. Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing. PLoS One. 2013,8(5):e63674. doi: 10.1371/journal.pone.0063674Read this paper
- Kim YJ, Lee HJ, Kim TM, et al. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α. Int J Cancer. 2013,132(1):29-41. doi: 10.1002/ijc.27666Read this paper
- Kumar V, Scandella E, Danuser R, et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood. 2010,115(23):4725-33. doi: 10.1182/blood-2009-10-250118Read this paper
- Kilarski WW, Samolov B, Petersson L, et al. Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med. 2009,15(6):657-64. doi: 10.1038/nm.1985Read this paper
